22:54 , Aug 1, 2019 |  BC Innovations  |  Product Development

NeuBase takes antisense oligos to more targets in more places

Newcomer NeuBase Therapeutics is re-engineering antisense oligos to access a broader range of targets, while simultaneously solving the modality’s dosing and delivery issues. With three approvals since the start of 2016, antisense oligonucleotides (ASOs) have...
23:20 , Jul 26, 2019 |  BC Extra  |  Company News

Management tracks: Obsidian builds out team; plus Agilvax, Selvita, NeuBase and more

Obsidian Therapeutics (Cambridge, Mass.) hired Catherine Stehman-Breen as chief development officer, Ryan Daws as CFO, and Karen Brown as SVP, intellectual property and legal affairs. Stehman-Breen was CMO of Atlas Venture-backed Dyne Therapeutics Inc. (Cambridge,...
22:01 , Oct 4, 2018 |  BC Innovations  |  Tools & Techniques

Lilly: academic about manufacturing

As Eli Lilly and Co. moves toward continuous manufacturing, the pharma is deepening ties with two academic centers to meet an array of engineering challenges. Through partnerships with Carnegie Mellon University, and the U.K.’s Imperial...
17:21 , Aug 30, 2018 |  BC Innovations  |  Tools & Techniques

Master of autism

The discovery of a master regulator of autism risk genes has yielded the first mouse model of the form of the condition that accounts for about 90% of patients, and could spark a new way...
18:59 , Nov 3, 2017 |  BC Week In Review  |  Financial News

BioArctic prices SSE IPO

On Oct. 12, neurodegenerative disease company BioArctic AB (SSE:BIOA B) raised SEK700 million ($83.6 million) through the sale of 29.2 million shares at SEK24 in an IPO on NASDAQ Stockholm underwritten by Carnegie Investment Bank...
20:30 , Jun 23, 2017 |  BC Week In Review  |  Financial News

BoneSupport raises SEK500M in IPO

On June 21, bioceramics company BoneSupport AB (SSE:BONEX) raised SEK500 million ($57.2 million) through the sale of 17.2 million shares at SEK29 in an IPO underwritten by Carnegie Investment Bank and ABG Sundal Collier. Swedbank...
20:23 , Jun 21, 2017 |  BC Extra  |  Financial News

BoneSupport rises after SEK500M IPO

Bioceramics company BoneSupport AB (SSE:BONEX) rose SEK3 (10%) to SEK32 in its first day of trading Wednesday after it raised SEK500 million ($57.2 million) through the sale of 17.2 million shares at SEK29 in an...
02:16 , Apr 22, 2017 |  BioCentury  |  Finance

Sweden heating up

Following a nearly 15-year deep freeze, Stockholm has become one of the hottest European markets for biotech IPOs. The recent boom reflects a ripening of several years of investment in the early stage life sciences...
23:53 , Feb 24, 2017 |  BC Extra  |  Financial News

Oncopeptides raises SEK650M in IPO

Oncopeptides AB (SSE:ONCO) gained SEK2.4 to SEK44.3 in its first day of trading after raising SEK650 million ($72.7 million) through the sale of 14.1 million shares at SEK46 in an IPO underwritten by ABG Sundal...
21:36 , Feb 24, 2017 |  BC Week In Review  |  Financial News

Oncopeptides completes IPO

On Feb. 22, cancer company Oncopeptides AB (SSE:ONCO) raised SEK650 million ($72.7 million) through the sale of 14.1 million shares at SEK46 in an IPO underwritten by ABG Sundal Collier, Carnegie Investment Bank and DNB...